LARGE1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Overexpression of LARGE (or LARGE2) by means of genetic or pharmacological intervention could restore ligand binding and improve muscle strength in patients affected by dystroglycanopathies.